Cargando…
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression
Recent data indicate that receptor for activated C kinase 1 (RACK1) is a putative prognostic marker and drug target in breast cancer (BC). High RACK1 expression is negatively associated with overall survival, as it seems to promote BC progression. In tumors, RACK1 expression is controlled by a compl...
Autores principales: | Masi, Mirco, Garattini, Enrico, Bolis, Marco, Di Marino, Daniele, Maraccani, Luisa, Morelli, Elena, Grolla, Ambra A., Fagiani, Francesca, Corsini, Emanuela, Travelli, Cristina, Govoni, Stefano, Racchi, Marco, Buoso, Erica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732991/ https://www.ncbi.nlm.nih.gov/pubmed/33311444 http://dx.doi.org/10.1038/s41389-020-00291-x |
Ejemplares similares
-
Endocrine-Disrupting Chemicals’ (EDCs) Effects on Tumour Microenvironment and Cancer Progression: Emerging Contribution of RACK1
por: Buoso, Erica, et al.
Publicado: (2020) -
Effects of Bisphenols on RACK1 Expression and Their Immunological Implications in THP-1 Cells
por: Buoso, Erica, et al.
Publicado: (2021) -
Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers
por: Masi, Mirco, et al.
Publicado: (2021) -
The coupling of RACK1 with the beta isoform of the glucocorticoid receptor promotes resilience to chronic stress exposure
por: Brivio, Paola, et al.
Publicado: (2021) -
Role of Hormones in the Regulation of RACK1 Expression as a Signaling Checkpoint in Immunosenescence
por: Racchi, Marco, et al.
Publicado: (2017)